Embed Size (px)
Citation preview
CHAPTER 7.
BIBLIOGRAPHY
Bibliography
7. Bibliography
• Akesson, M., E. N. Karlsson, P. Hagander, J. P. Axelsson, and A. Tocaj. 1999. On
line detection of acetate formation in Escherichia coli cultures using dissolved oxygen
responses to feed transients. Biotechnol Bioeng 64:590-8.
• Amrein, K. E., B. Takacs, M. Stieger, J. Molnos, N. A. Flint, and P. Burn. 1995.
Purification and characterization of recombinant human p50csk protein-tyrosine kinase
from an Escherichia coli expression system overproducing the bacterial chaperones
GroES and GroEL. Proc Natl Acad Sci U S A 92:1048-52.
• Andersen, K. B., and K. von Meyenburg. 1980. Are growth rates of Escherichia coli in
batch cultures limited by respiration? J Bacterial 144:114-23.
• Arakawa, T., and S. N. Timasheff. 1982. Stabilization of protein structure by sugars.
Biochemistry 21 :6536-44.
• Arakawa, T., and S. N. Timasheff. 1985. Mechanism of poly(ethylene glycol) interaction
with proteins. Biochemistry 24:6756-62.
• Ariga, 0., Y. Andoh, Y. Fujishita, T. Watari, and Y. Sano. 1991. Production of
thermophilic a-amylase using immobilized transformed Escherichia coli by addition of
glycine. J. Ferment. Bioeng.71: 397-402.
• Aristidou, A. A., K. Y. San, and G. N. Bennett. 1995. Metabolic engineering of
Escherichia coli to enhance recombinant protein production through acetate reduction.
Biotechnol Prog 11:475-8.
• Aristidou, A. A., K. Y. San, and G. N. Bennett. 1999. Improvement of biomass yield
and recombinant gene expression in Escherichia coli by using fructose as the primary
carbon source. Biotechnol Prog 15:140-5.
• Aritomi, M., N. Kunishima, T. Okamoto, R. Kuroki, Y. Ota, and K. Morikawa. 1999.
Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor
recognition scheme. Nature 401:713-7.
• Arnold, S. A., R. Gaensakoo, L. M. Harvey, and B. McNeil. 2002. Use of at-line and
in-situ near-infrared spectroscopy to monitor biomass in an industrial fed-batch
Escherichia coli process. Biotechnol Bioeng 80:405-13.
129
Bibliography
• Baba, M., H. Hasegawa, M. Nakayabu, N. Shimizu, S. Suzuki, N. Kamada, and K.
Tani. 1995. Establishment and characteristics of a gastric cancer cell line (HuGC
OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine
growth control by G-CSF. Am J Hemato149:207-15.
• Babu, K. R., S. Swaminathan, S. Marten, N. Khanna, and U. Rinas. 2000. Production
of interferon-alpha in high cell density cultures of recombinant Escherichia coli and its
single step purification from refolded inclusion body proteins. Appl Microbial Biotechnol
53:655-60.
• Bachinger, T., U. Riese, R. Eriksson, and C. F. Mandenius. 2000. Monitoring cellular
state transitions in a production-scale CHO-cell process using an electronic nose. J
Biotechnol 76:61-71.
• Bae, C. S., D. S. Yang, J. Lee, and Y. H. Park. 1999. Improved process for production
of recombinant yeast-derived monomeric human G-CSF. Appl Microbial Biotechnol
52:338-44.
• Bae, C. S., D. S. Yang, K. R. Chang, B. L. Seong, and J. Lee. 1998. Enhanced
secretion of human granulocyte colony-stimulating factor directed by a novel hybrid
fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration.
Biotechnol Bioeng 57:600-9.
• Baneyx, F., and G. Georgiou. 1992. Degradation of secreted proteins in Escherichia
coli. Ann NY Acad Sci 665:301-8.
• Baneyx, F., and M. Mujacic. 2004. Recombinant protein folding and misfolding in
Escherichia coli. Nat Biotechnol 22:1399-408.
• Bardwell, J. C. 1994. Building bridges: disulphide bond formation in the cell. Mol
Microbial 14:199-205.
• Bech Jensen E., and S. Carlsen. 1990. Production of recombinant human growth
hormone in Escherichia coli: Expression of different precursors and physiological effects
of glucose, acetate, and salts. Biotechnology and Bioengineering. 36:1-11.
• Belasco, J. G., G. Nilsson, A. von Gabain, and 5. N. Cohen. 1986. The stability of E.
coli gene transcripts is dependent on determinants localized to specific mRNA
segments. Cell 46:245-51.
• Bendig, M. M. 1988. The production of foreign proteins in mammalian cells. Genet
130
Bibliography
Eng:91-127.
• Berkow, R. (ed.). 1992. The Merck manual of diagnosis and therapy, Merck Research
Laboratories, Rahway, N.J. 161h ed., p. 24-30.
• Bermejo, L. L., N. E. Welker, and E. T. Papoutsakis. 1998. Expression of Clostridium
acetobutylicum A TCC 824 genes in Escherichia coli for acetone production and acetate
detoxification. Appl Environ Microbial 64:1079-85.
• Blight, M. A., and I. B. Holland. 1994. Heterologous protein secretion and the versatile
Escherichia coli haemolysin translocator. Trends Biotechnol 12:450-5.
• Bowden, G. A., and G. Georgiou. 1990. Folding and aggregation of beta-lactamase in
the periplasmic space of Escherichia coli. J Bioi Chem 265:16760-6.
• Brems, David. N. 2002. The kinetics of G-CSF folding. Protein science 11:2504- 2511
• Bronchud, M. H., A. Howell, D. Crowther, P. Hopwood, L. Souza, and T. M. Dexter.
1989. The use of granulocyte colony-stimulating factor to increase the intensity of
treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J
Cancer 60:121-5.
• Bronchud, M. H., M. R. Potter, G. Morgenstern, M. J. Blasco, J. H. Scarffe, N.
Thatcher, D. Crowther, L. M. Souza, N. K. Alton, N. G. Testa, and et al. 1988. In vitro
and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating
factor in patients. Br J Cancer 58:64-9.
• Brown, W. C., and J. L. Campbell. 1993. A new cloning vector and expression strategy
for genes encoding proteins toxic to Escherichia coli. Gene 127:99-103.
• Cabilly, S. 1989. Growth at sub-optimal temperatures allows the production of
functional, antigen-binding Fab fragments irt Escherichia coli. Gene 85:553-7.
• Cannizzaro, C., R. Gugerli, I. Marison, and U. von Stockar. 2003. On-line biomass
monitoring of CHO perfusion culture with scanning dielectric spectroscopy. Biotechnol
Bioeng 84:597-610.
• Carter, C. R., K. M. Whitmore, and R. Thorpe. 2004. The significance of carbohydrates
on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation. J
Leukoc Bioi 75:515-22.
• Carver, A. S., M. A. Dalrymple, G. Wright, D. S. Cottom, D. B. Reeves, Y. H. Gibson,
131
Bibliography
J. L. Keenan, J. D. Barrass, A. R. Scott, A. Colman, and et al. 1993. Transgenic
livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of
sheep. Biotechnology (N Y) 11:1263-70.
• Chen, G. T., and M. Inouye. 1994. Role of the AGA/AGG codons, the rarest codons in
global gene expression in Escherichia coli. Genes Dev 8:2641-52.
• Chen, L. H., S. A. Emory, A. L. Bricker, P. Bouvet, and J. G. Belasco. 1991.
Structure and function of a bacterial mRNA stabilizer: analysis of the 5' untranslated
region of ompA mRNA. J Bacterial 173:4578-86.
• Chen, R., V. Hatzimanikatis, W. M. Yap, P. W. Postma, and J. E. Bailey. 1997.
Metabolic consequences of phosphotransferase (PTS) mutation in a phenylalanine
producing recombinant Escherichia coli. Biotechnol Prog 13:768-75.
• Chen, W., P. T. Kallio, and J. E. Bailey. 1995. Process characterization of a novel
cross-regulation system for cloned protein production in Escherichia coli. Biotechnol
Prog 11:397-402.
• Chen, X., P. Cen, and J. Chen. 2005. Enhanced production of human epidermal growth
factor by a recombinant Escherichia coli integrated with in situ exchange of acetic acid
by macroporous ion-exchange resin. J Biosci Bioeng 100:579-81.
• Chothia, C., M. Levitt, and D. Richardson. 1977. Structure of proteins: packing of
alpha-helices and pleated sheets. Proc Natl Acad Sci U SA 74:4130-4.
• Coleman, J., M. Inouye, and K. Nakamura. 1985. Mutations upstream of the ribosome
binding site affect translational efficiency. J Mol Bioi 181:139-43.
• Collins-Racie, L. A., J. M. McColgan, K. L. Grant, E. A. DiBiasio-Smith, J. M.
McCoy, and E. R. LaVallie. 1995. Production of recombinant bovine enterokinase
catalytic subunit in Escherichia coli using the novel secretory fusion partner DsbA.
Biotechnollogy (N Y) 13:982-7.
• Covalt JC, Jr., Cao TB, Magdaroag JR, Gross LA, Jennings PA. 2005. Temperature,
media, and point of induction affect the N-terminal processing of interleukin-1 beta.
Protein Expr Purif 41:45-52.
• Curless, C., J. Pope, and L. Tsai. 1990. Effect of preinduction specific growth rate on
recombinant alpha consensus interferon synthesis in Escherichia coli. Biotechnol Prog
6:149-52.
132
Bibliography
• Dale, D. C., M. A. Bonilla, M. W. Davis, A. M. Nakanishi, W. P. Hammond, J.
Kurtzberg, W. Wang, A. Jakubowski, E. Winton, P. Lalezari, and et al. 1993. A
randomized controlled phase Ill trial of recombinant human granulocyte colony
stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood
81 :2496-502.
• De Anda, R., A. R. Lara, V. Hernandez, V. Hernandez-Montalvo, G. Gosset, F.
Bolivar, and 0. T. Ramirez. 2006. Replacement of the glucose phosphotransferase
transport system by galactose permease reduces acetate accumulation and improves
process performance of Escherichia coli for recombinant protein production without
impairment of growth rate. Metab Eng 8:281-90.
• Devlin, P. E., R. J. Drummond, P. Toy, D. F. Mark, K. W. Watt, and J. J. Devlin.
1988. Alteration of amino-terminai codons of human granulocyte-colony-stimulating
factor increases expression levels and allows efficient processing by methionine
aminopeptidase in Escherichia coli. Gene 65:13-22.
• Dittrich, C. R., G. N. Bennett, and K. Y. San. 2005. Characterization of the acetate
producing pathways in Escherichia coli. Biotechnol Prog 21:1062-7.
• Divani, A. A., M.S. Hussain, E. Magal, R. F. Heary, and A. I. Qureshi. 2007. The use
of stem cells' hematopoietic stimulating factors therapy following spinal cord injury. Ann
Biomed Eng 35:1647-56.
• Dong H, Nilsson L, Kurland CG. 1995. Gratuitous overexpression of genes in
Escherichia coli leads to growth inhibition and ribosome destruction. J Bacterial
177:1497-504.
• Dvorianchikov, G. A., I. A. Serova, L. E. Andreeva, L. P. Dias, S. Azevedo, and 0. L.
Serov. 2005. [Secretion of biologically active human granulocyte colony-stimulating
factor (G-CSF) in milk of transgenic mice]. Genetika 41:1331-7.
• El Ouriaghli, F., H. Fujiwara, J. J. Melenhorst, G. Sconocchia, N. Hensel, and A. J.
Barrett. 2003. Neutrophil elastase enzymatically antagonizes the in vitro action of G
CSF: implications for the regulation of granulopoiesis. Blood 101:1752-8.
• Emory, S. A., P. Bouvet, and J. G. Belasco. 1992. A 5'-terminal stem-loop structure
can stabilize mRNA in Escherichia coli. Genes Dev 6:135-48.
• Enfors, S. 0. 1992. Control of in vivo proteolysis in the production of recombinant
133
Bibliography
proteins. Trends Biotechnol10:310-5.
• Esbensen, K., D. Kirsanov, A. Legin, A. Rudnitskaya, J. Mortensen, J. Pedersen, L.
Vognsen, S. Makarychev-Mikhailov, and Y. Vlasov. 2004. Fermentation monitoring
using multisensor systems: feasibility study of the electronic tongue. Anal Bioanal Chem
378:391-5.
• Fahey, R. C. 1977. Biologically important thiol-disulfide reactions and the role of
cyst(e)ine in proteins: an evolutionary perspective. Adv Exp Med Bioi86A:1-30.
• Farmer, W. R., and J. C. Liao. 1997. Reduction of aerobic acetate production by
Escherichia coli. Appl Environ Microbiol63:3205-10.
• Fehrenbach, H., J. Richter, and P. A. Schnabel. 1992. Electron spectroscopic study
(ESI, EELS) of Nanoplast-embedded mammalian lung. J Microsc 166:401-16.
• Fehrenbach, R., M. Comberbach, and J. 0. Petre. 1992. On-line biomass monitoring
by capacitance measurement. J Biotechnol 23:303-14.
• Feng, M., and J. Glassey. 2000. Physiological state-specific models in estimation of
recombinant Escherichia coli fermentation performance Biotechnol Bioeng 69:495-503.
• Fischer, B., I. Sumner, and P. Goodenough. 1992. Isolation and renaturation of bio
active proteins expressed in Escherichia coli as inclusion bodies. Arzneimittelforschung
42:1512-5.
• Frampton, J. E., C. R. Lee, and D. Faulds. 1994. Filgrastim. A review of its
pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48:731-60.
• Fukunaga, R., E. lshizaka-lkeda, C. X. Pan, Y. Seto, and S. Nagata. 1991. Functional
domains of the granulocyte colony-stimulating factor receptor. Embo J 10:2855-65.
• Georgiou, G., and P. Valax. 1996. Expression of correctly folded proteins in
Escherichia coli. Curr Opin Biotechnol 7:190-7.
• Glaspy, J. A., G. C. Baldwin, P. A. Robertson, L. Souza, M. Vincent, J. Ambersley,
and D. W. Golde. 1988. Therapy for neutropenia in hairy cell leukemia with recombinant
human granulocyte colony-stimulating factor. Ann Intern Med 109:789-95.
• Glibetic, M., L. Taylor, D. Larson, R. Hannan, B. Sells, and L. Rothblum. 1995. The
RNA polymerase I transcription factor UBF is the product of a primary response gene. J
Bioi Chern 270:4209-12.
134
Bibliography
• Gorenflo, V., A. Steinbuchel, S. Marose, M. Rieseberg, and T. Scheper. 1999.
Quantification of bacterial polyhydroxyalkanoic acids by Nile red staining. Appl Microbial
Biotechnol 51:765-72.
• Gourse RL, Takebe Y, Sharrock RA, Nomura M. 1985. Feedback regulation of rRNA
and tRNA synthesis and accumulation of free ribosomes after conditional expression of
rRNA genes. Proc Natl Acad Sci U S A 82:1069-73.
• Gross, G., C. Mielke, I. Hollatz, H. Blocker, and R. Frank. 1990. RNA primary
sequence or secondary structure in the translational initiation region controls expression
of two variant interferon-beta genes in Escherichia coli. J Bioi Chem 265:17627-36.
• Guzman, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation,
modulation, and high-level expression by vectors containing the arabinose PBAD
promoter. J Bacterial 177:4121-30.
• Hammarberg, B., P. A. Nygren, E. Holmgren, A. Elmblad, M. Tally, U. Hellman, T.
Moks, and M. Uhlen. 1989. Dual affinity fusion approach and its use to express
recombinant human insulin-like growth factor II. Proc Natl Acad Sci US A 86:4367-71.
• Hattori, K., K. Shimizu, M. Takahashi, M. Tamura, M. Oheda, N. Ohsawa, and M.
Ono. 1990. Quantitative in vivo assay of human granulocyte colony-stimulating factor
using cyclophosphamide-induced neutropenic mice. Blood 75:1228-33.
• Heil, G., D. Hoelzer, M. A. Sanz, K. Lechner, J. A. Liu Yin, G. Papa, L. Noens, J.
Szer, A. Ganser, C. O'Brien, J. Matcham, and A. Barge. 1997. A randomized, double
blind, placebo-controlled, phase Ill study of filgrastim in remission induction and
consolidation therapy for adults with de novo acute myeloid leukemia. The International
Acute Myeloid Leukemia Study Group. Blood 90:4710-8.
• Herbst, B., S. Kneip, and E. Bremer. 1994. pOSEX: vectors for osmotically controlled
and finely tuned gene expression in Escherichia coli. Gene 151:137-42.
• Herman, A. C., T. C. Boone, and H. S. Lu. 1996. Characterization, formulation, and
stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating
factor. Pharm Biotechnol 9:303-28.
• Holms WH. 1986. The central metabolic pathways of Escherichia coli: relationship
between flux and control at a branch point, efficiency of conversion to biomass, and
excretion of acetate. Curr Top Cell Regul28:69-105.
135
Bibliography
• Hughes, D. E., J. E. Curtis, C. Khosla, and J. E. Bailey. 1989. A new oxygen
regulated promoter for the expression of proteins in Escherichia coli. Biotechniques
7:1026-8.
• lchiishi, E., T. Yoshikawa, T. Kogawa, N. Yoshida, and M. Kondo. 2000. Possible
paracrine growth of adenocarcinoma of the stomach induced by granulocyte colony
stimulating factor produced by squamous cell carcinoma of the oesophagus. Gut
46:432-4.
• luchi, S., and E. C. Lin. 1988. areA (dye}, a global regulatory gene in Escherichia coli
mediating repression of enzymes in aerobic pathways. Proc Natl Acad Sci U S A
85:1888-92.
• Jensen KF, Pedersen S. 1990. Metabolic growth rate control in Escherichia coli may be
a consequence of subsaturation of the macromolecular biosynthetic apparatus with
substrates and catalytic components. Microbial Rev 54:89-100.
• Jeong, K. J., and S. Y. Lee. 1999. High-level production of human leptin by fed-batch
cultivation of recombinant Escherichia coli and its purification. Appl Environ Microbial
65:3027-32.
• Jeong, K. J., and S. Y. Lee. 2001. Secretory production of human granulocyte colony
stimulating factor in Escherichia coli. Protein Expr Purif 23:311-8.
• Jevsevar, 5., V. Gaberc-Porekar, I. Fonda, B. Podobnik, J. Grdadolnik, and V.
Menart. 2005. Production of nonclassical inclusion bodies from which correctly folded
protein can be extracted. Biotechnol Prog 21 :632-9.
• Johnston, W., R. Cord-Ruwisch, and M. J. Cooney. 2002. Industrial control of
recombinant E. coli fed-batch culture: new perspectives on traditional controlled
variables. Bioprocess Biosyst Eng 25:111-20.
• Jung, G., P. Denefle, J. Becquart, and J. F. Mayaux. 1988. High-cell density
fermentation studies of recombinant Escherichia coli strains expressing human
interleukin-1 beta. Ann I nst Pasteur Microbial 139:129-46.
• Kadonaga, J. T., A. E. Gautier, D. R. Straus, A. D. Charles, M. D. Edge, and J. R.
Knowles. 1984. The role of the beta-lactamase signal sequence in the secretion of
proteins by Escherichia coli. J Bioi Chem 259:2149-54.
136
Bibliography
• Kayser, A, J. Weber, V. Hecht and U. Rinas. 2005. Metabolic flux analysis of
Escherichia coli in glucose-limited continuous culture. I. Growth-ratedependent
metabolic efficiency at steady state. Microbiology 151: 693-706
• Khosla, C., and J. E. Bailey. 1989. Characterization of the oxygen-dependent promoter
of the Vitreoscilla hemoglobin gene in Escherichia coli. J Bacteriol171 :5995-6004.
• Kleman, G. L., and W. R. Strohl. 1994. Developments in high cell density and high
productivity microbial fermentation. Curr Opin Biotech no I 5:180-6.
• Knorre WA, Deckwer WD, Korz D, Pohl HD, Riesenberg D, Ross A, Sanders E,
Schulz V. 1991. High cell density fermentation of recombinant Escherichia coli with
computer-controlled optimal growth rate. Ann NY Acad Sci 646:300-6.
• Ko, J. H., C. S. Lee, K. H. Kim, M. G. Pang, J. S. Koo, N. Fang, D. B. Koo, K. B. Oh,
W. S. Youn, G. D. Zheng, J. S. Park, S. J. Kim, Y. M. Han, I. Y. Choi, J. Lim, S. T.
Shin, S. W. Jin, K. K. Lee, and 0. J. Yoo. 2000. Production of biologically active
human granulocyte colony stimulating factor in the milk of transgenic goat. Transgenic
Res 9:215-22.
• Komine-Kobayashi, M., N. Zhang, M. Liu, R. Tanaka, H. Hara, A. Osaka, H.
Mochizuki, Y. Mizuno, and T. Urabe. 2006. Neuroprotective effect of recombinant
human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb
Blood Flow Metab 26:402-13.
• Krishnan, S., E. Y. Chi, J. N. Webb, B. S. Chang, D. Shan, M. Goldenberg, M. C.
Manning, T. W. Randolph, and J. F. Carpenter. 2002. Aggregation of granulocyte
colony stimulating factor under physiological conditions: characterization and
thermodynamic inhibition. Biochemistry 41:6422-31.
• Kubota, N., T. Orita, K. Hattori, M. Oh-eda, N. Ochi, and T. Yamazaki. 1990.
Structural characterization of natural and recombinant human granulocyte colony
stimulating factors. J Biochem (Tokyo) 107:486-92.
• Kwon, S., S. Kim, and E. Kim. 1996. Effects of glycerol of beta-lactamase production
during high cell density cultivation of recombinant Escherichia coli. Biotechnol Prog
12:205-8.
• Laminet, A. A., C. A. Kumamoto, and A. Pluckthun. 1991. Folding in vitro and
transport in vivo of pre-beta-lactamase are SeeS independent. Mol Microbial 5:117-22.
137
Bibliography
• Lasnik, M. A., V. G. Porekar, and A. Stale. 2001. Human granulocyte colony
stimulating factor (hG-CSF) expressed by methylotrophic yeast pichia pastoris. Pflugers
Arch 442: R 184-6.
• LaVallie, E. R., E. A. DiBlasio, S. Kovacic, K. L. Grant, P. F. Schendel, and J. M.
McCoy. 1993. A thioredoxin gene fusion expression system that circumvents inclusion
body formation in the E. coli cytoplasm. Biotechnology (N Y) 11:187-93.
• Lee, J. H., N. S. Kim, T. H. Kwon, Y. S. Jang, and M. S. Yang. 2002. Increased
production of human granulocyte-macrophage colony stimulating factor (hGM-CSF) by
the addition of stabilizing polymer in plant suspension cultures. J Biotechnol 96:205-11.
• Lee, S. C., and P. 0. Olins. 1992. Effect of overproduction of heat shock chaperones
GroESL and DnaK on human procollagenase production in Escherichia coli. J Bioi Chem
267:2849-52.
• Lee, S. Y. 1996. High cell-density culture of Escherichia coli. Trends Biotechnol 14:98-
105.
• Lu, C. Z., and B. G. Xiao. 2006. G-CSF and neuroprotection: a therapeutic perspective
in cerebral ischaemia. Biochem Soc Trans 34:1327-33.
• Lu, H. S., C. L. Clogston, L. 0. Narhi, L. A. Merewether, W. R. Pearl, and T. C.
Boone. 1992. Folding and oxidation of recombinant human granulocyte colony
stimulating factor produced in Escherichia coli. Characterization of the disulfide-reduced
intermediates and cysteine----serine analogs. J Bioi Chem 267:8770-7.
• Luo, Q., Y. L. Shen, D. Z. Wei, and W. Cao. 2006. Optimization of culture on the
overproduction of TRAIL in high-cell-density culture by recombinant Escherichia coli.
Appl Microbial Biotechnol 71:184-91.
• Makrides, S. C. 1996. Strategies for achieving high-level expression of genes in
Escherichia coli. Microbial Rev 60:512-38.
• Marose, S., C. Lindemann, and T. Scheper. 1998. Two-dimensional fluorescence
spectroscopy: a new tool for on-line bioprocess monitoring. Biotechnol Prog 14:63-74.
• Maurizi, M. R. 1992. Proteases and protein degradation in Escherichia coli. Experientia
48:178-201.
• Meerman, H. J., and G. Georgiou. 1994. Construction and characterization of a set of
E. coli strains deficient in all known loci affecting the proteolytic stability of secreted
138
Bibliography
recombinant proteins. Biotechnology (N Y) 12:1107-10.
• Mertens, N., E. Remaut, and W. Fiers. 1995. Tight transcriptional control mechanism
ensures stable high-level expression from T7 promoter-based expression plasmids.
Biotechnology (N Y) 13:175-9.
• Metcalf, D. 1998. Cell-cell signalling in the regulation of blood cell formation and
function. lmmunol Cell Bioi 76:441-7.
• Minas, W., and J. E. Bailey. 1995. Co-overexpression of priF increases cell viability and
enzyme yields in recombinant Escherichia coli expressing Bacillus stearothermophilus
alpha-amylase. Biotechnol Prog 11:403-11.
• Missiakas, D., F. Schwager, and S. Raina. 1995. Identification and characterization of
a new disulfide isomerase-like protein (DsbD) in Escherichia coli. Embo J 14:3415-24.
• Morino, T., M. Morita, K. Seya, Y. Sukenaga, K. Kato, and T. Nakamura.1988.
Construction of a runaway vector and its use for a high-level expression of a cloned
human superoxide dismutase gene. Appl. Microbial. Biotechnol 28:170-175.
• Murby, M., L. Cedergren, J. Nilsson, P. A. Nygren, B. Hammarberg, B. Nilsson, 5.
0. Enfors, and M. Uhlen. 1991. Stabilization of recombinant proteins from proteolytic
degradation in Escherichia coli using a dual affinity fusion strategy. Biotechnol Appl
Biochem 14:336-46.
• Murby, M., M. Uhlen, and 5. Stahl. 1996. Upstream strategies to minimize proteolytic
degradation upon recombinant production in Escherichia coli. Protein Expr Purif 7:129-
36.
• Nagata, S. 1989. Gene structure and function of granulocyte colony-stimulating factor.
Bioessays 10:113-7.
• Nagata, S., and R. Fukunaga. 1991. Granulocyte colony-stimulating factor and its
receptor. Prog Growth Factor Res 3: 131-41.
• Nagata, S., M. Tsuchiya, S. Asano, 0. Yamamoto, Y. Hirata, N. Kubota, M. Oheda,
H. Nomura, and T. Yamazaki. 1986. The chromosomal gene structure and two mRNAs
for human granulocyte colony-stimulating factor. Embo J 5:575-81.
• Nagata, S., M. Tsuchiya, S. Asano, Y. Kaziro, T. Yamazaki, 0. Yamamoto, Y. Hirata,
N. Kubota, M. Oheda, H. Nomura, and et al. 1986. Molecular cloning and expression
of eDNA for human granulocyte colony-stimulating factor. Nature 319:415-8.
139
Bibliography
• Nakano, K., M. Rischke, S. Sato, and H. Markl. 1997. Influence of acetic acid on the
growth of Escherichia coli K12 during high-cell-density cultivation in a dialysis reactor.
Appl Microbial Biotechnol48:597-601.
• Neri, D., C. de Lalla, H. Petrul, P. Neri, and G. Winter. 1995. Calmodulin as a versatile
tag for antibody fragments. Biotechnology (NY) 13:373-7.
• Neubauer, P., H. Y. Lin, and B. Mathiszik. 2003. Metabolic load of recombinant protein
production: inhibition of cellular capacities for glucose uptake and respiration after
induction of a heterologous gene in Escherichia coli. Biotechnol Bioeng 83:53-64.
• Niccolai, A., S. Fontani, A. Kapat, and R. Olivieri. 2003. Maximization of recombinant
Helicobacter pylori neutrophil activating protein production in Escherichia coli:
improvement of a chemically defined medium using response surface methodology.
FEMS Microbial Lett 221 :257-62.
• Nilsson, J., S. Stahl, J. Lundeberg, M. Uhlen, and P. A. Nygren. 1997. Affinity fusion
strategies for detection, purification, and immobilization of recombinant proteins. Protein
Expr Purif 11: 1-16.
• Nissen, C. 1994. Glycosylation of recombinant human granulocyte colony stimulating
factor: implications for stability and potency. Eur J Cancer 30A Suppl 3:812-4.
• Nordstrom, K., and B. E. Uhlin. 1992. Runaway-replication plasmids as tools to
produce large quantities of proteins from cloned genes in bacteria. Biotechnology (N Y)
10:661-6.
• Oh-eda, M., M. Hasegawa, K. Hattori, H. Kuboniwa, T. Kojima, T. Orita, K.
Tomonou, T. Yamazaki, and N. Ochi. 1990. 0-linked sugar chain of human
granulocyte colony-stimulating factor protects it against polymerization and denaturation
allowing it to retain its biological activity. J Bioi Chem 265:11432-5.
• Paalme, T., R. Elken, A. Kahru, K. Vanatalu, and R. Vilu. 1997. The growth rate
control in Escherichia coli at near to maximum growth rates: the A-stat approach.
Antonie Van Leeuwenhoek 71 :217-30.
• Panda, A. K., R. H. Khan, K. B. Rao, and S. M. Totey. 1999. Kinetics of inclusion body
production in batch and high cell density fed-batch culture of Escherichia coli expressing
ovine growth hormone. J Biotechnol75:161-72.
• Petrovskaia, L. E., A. V. Ruzin, L. N. Shingarova, and V. G. Korobko. 1995. [Design
140
Bibliography
of recombinant Escherichia coli strains, determining the secretory expression of artificial
human granulocyte-macrophage colony-stimulating factor genes]. Bioorg Khim 21:845-
54.
• Phue, J. N., and J. Shiloach. 2004. Transcription levels of key metabolic genes are the
cause for different glucose utilization pathways in E. coli B (BL21) and E. coli K (JM109).
J Biotechnol 109:21-30.
• Picon, A., M. J. Teixeira de Mattos, and P. W. Postma. 2005. Reducing the glucose
uptake rate in Escherichia coli affects growth rate but not protein production. Biotechnol
Bioeng 90:191-200.
• Pollitt, S., and H. Zalkin. 1983. Role of primary structure and disulfide bond formation in
beta-lactamase secretion. J Bacteriol153:27-32.
• Ponce, E. 1999. Effect of growth rate reduction and genetic modifications on acetate
accumulation and biomass yields in Escherichia coli. J Biosci Bioeng 87:775-80.
• Prunkard, D., I. Cottingham, I. Garner, S. Bruce, M. Dalrymple, G. Lasser, P.
Bishop, and D. Foster. 1996. High-level expression of recombinant human fibrinogen in
the milk of transgenic mice. Nat Biotechnol14:867-71.
• Pugsley, A. P., 0. Francetic, K. Hardie, 0. M. Possot, N. Sauvonnet, and A. Seydel.
1997. Pullulanase: model protein substrate for the general secretory pathway of gram
negative bacteria. Folia Microbial (Praha) 42:184-92.
• Riesenberg D, Schulz V, Knorre WA, Pohl HD, Korz D, Sanders EA, Ross A,
Deckwer WD. 1991. High cell density cultivation of Escherichia coli at controlled specific
growth rate. J Biotechnol 20:17-27.
• Rudolph, R., and H. Lilie. 1996. In vitro folding of inclusion body proteins. Faseb J
10:49-56.
• Ryu, D. D., and R. Siegel. 1986. Scale-up of fermentation processes using recombinant
microorganisms. Ann N Y Acad Sci 469:73-82.
• Saccardi R, Avanzi G, Bezzini R. 1997. Mobilization of PBSC for hematological rescue:
comparison between glycosylated and non-glycosylated G-CSF. Bone Marrow
Transplant 19:(Suppl. 11) 511.
• San, K. Y., G. N. Bennett, A. A. Aristidou, and C. H. Chou. 1994. Strategies in high
level expression of recombinant protein in Escherichia coli. Ann N Y Acad Sci 721 :257-
141
Bibliography
67.
• San, K. Y., G. N. Bennett, C. H. Chou, and A. A. Aristidou. 1994. An optimization
study of a pH-inducible promoter system for high-level recombinant protein production in
Escherichia coli. Ann NY Acad Sci 721:268-76.
• Sanden, A. M., I. Prytz, I. Tubulekas, C. Forberg, H. Le, A. Hektor, P. Neubauer, Z.
Pragai, C. Harwood, A. Ward, A. Picon, J. T. De Mattos, P. Postma, A. Farewell, T.
Nystrom, S. Reeh, S. Pedersen, and G. Larsson. 2003. Limiting factors in Escherichia
coli fed-batch production of recombinant proteins. Biotechnol Bioeng 81:158-66.
• Sandkvist, M., and M. Bagdasarian. 1996. Secretion of recombinant proteins by Gram
negative bacteria. Curr Opin Biotechnol 7:505-11.
• Schabitz, W. R., R. Kollmar, M. Schwaninger, E. Juettler, J. Bardutzky, M. N.
Scholzke, C. Sommer, and S. Schwab. 2003. Neuroprotective effect of granulocyte
colony-stimulating factor after focal cerebral ischemia. Stroke 34:745-51.
• Schein, C. H. 1991. Optimizing protein folding to the native state in bacteria. Curr Opin
Biotechnol 2:746-50.
• Schneider, A., C. Kruger, T. Steigleder, D. Weber, C. Pitzer, R. Laage, J.
Aronowski, M. H. Maurer, N. Gassier, W. Mier, M. Hasselblatt, R. Kollmar, S.
Schwab, C. Sommer, A. Bach, H. G. Kuhn, and W. R. Schabitz. 2005. The
hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death
and drives neurogenesis. J Clin Invest 115:2083-98.
• Schneider, A., H. G. Kuhn, and W. R. Schabitz. 2005. A role for G-CSF (granulocyte
colony stimulating factor) in the central nervous system. Cell Cycle 4:1753-7.
• Schneider, A., R. Wysocki, C. Pitzer, C. Kruger, R. Laage, S. Schwab, A. Bach, and
W. R. Schabitz. 2006. An extended window of opportunity for G-CSF treatment in
cerebral ischemia. BMC Bioi 4:36.
• Schugerl, K. 2001. Progress in monitoring, modeling and control of bioprocesses during
the last 20 years. J Biotechnol 85:149-73.
• Seo, J. H., and J. E. Bailey. 1986. Continuous cultivation of recombinant Escherichia
coli: Existence of an optimum dilution rate for maximum plasmid and gene product
concentration. Biotechnol Bioeng 28:1590-4.
• Shang, X., H. Yin, A. Lu, and L. Zhang. 1999. Application of recombinant human
142
Bibliography
granulocyte colony stimulating factor in children with acute myeloid leukemia. Chin Med
J (Engl) 112:620-2.
• Shin CS, Hong MS, Kim DY, Shin HC, Lee J. 1998. Growth-associated synthesis of
recombinant human glucagon and human growth hormone in high-cell-density cultures
of Escherichia coli. Appl Microbial Biotechnol494:364-70.
• Shin, C. S., M.S. Hong, C. S. Bae, and J. Lee. 1997. Enhanced production of human
mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli
BL21 (DE3)[pET -3aT2M2]. Biotechnol Prog 13:249-57.
• Shin-Young Hong, Tae-Ho Kwon, Jae-Hwa Lee, Yong-Suk Jang and Moon-Sik
Yang. 2002. Production of biologically active hG-CSF by transgenic plant cell
suspension culture. Enzyme and Microbial Technology 30:763-767.
• Shirafuji, N., S. Asano, S. Matsuda, K. Watari, F. Takaku, and S. Nagata. 1989. A
new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine
myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal
healthy persons and patients with infectious and hematological disorders. Exp Hematol
17:116-9.
• Shirafuji, N., S. Matsuda, H. Ogura, K. Tani, H. Kodo, K. Ozawa, S. Nagata, S.
Asano, and F. Takaku. 1990. Granulocyte colony-stimulating factor stimulates human
mature neutrophilic granulocytes to produce interferon-alpha. Blood 75:17-9.
• Shirano, Y., and D. Shibata. 1990. Low temperature cultivation of Escherichia coli
carrying a rice lipoxygenase L-2 eDNA produces a soluble and active enzyme at a high
level. FEBS Lett 271:128-30.
• Siegel, R, Ryu D. D. Y, 1985. Kinetic study instability of recombinant plasmid pPLc23trp
in E.coli using two stage continuous culture system. Biotechnology Bioengineering 27:
28-33.
• Siegel, R., Ryu D. D. Y,. 1985. Kinetic study instability of recombinant plasmid
pPLc23trp in E.coli using two stage continuous culture system. Biotechnol. Bioeng 27:
28-33.
• Sivakesava, S., J. lrudayaraj, and A. Demirci. 2001. Monitoring a bioprocess for
ethanol production using FT-MIR and FT-Raman spectroscopy. J lnd Microbial
Biotechnol 26:185-90.
143
Bibliography
• Six, 1., G. Gasan, E. Mura, and R. Bordet. 2003. Beneficial effect of pharmacological
mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacal
458:327-8.
• Skibsted, E., C. Lindemann, C. Roca, and L. Olsson. 2001. On-line bioprocess
monitoring with a multi-wavelength fluorescence sensor using multivariate calibration. J
Biotechnol 88:47-57.
• Souza, L. M., T. C. Boone, J. Gabrilove, P. H. Lai, K. M. Zsebo, D. C. Murdock, V. R.
Chazin, J. Bruszewski, H. Lu, K. K. Chen, and et al. 1986. Recombinant human
granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.
Science 232:61-5.
• Stahl, S., and P. A. Nygren. 1997. The use of gene fusions to protein A and protein G
in immunology and biotechnology. Pathol Bioi (Paris) 45:66-76.
• Stanssens, P., E. Remaut, and W. Fiers. 1985. Alterations upstream from the Shine-·
Dalgarno region and their effect on bacterial gene expression. Gene 36:211-23.
• Stark, E., B. Hitzmann, K. Schugerl, T. Scheper, C. Fuchs, D. Koster, and H. Markl.
2002. In-situ-fluorescence-probes: a useful tool for non-invasive bioprocess monitoring.
Adv Biochem Eng Biotechnol 74:21-38.
• Suzuki, T., T. Yamane, and S. Shimizu. 1990. Phenomenological background and
some preliminary trials of automated substrate supply in pH-stat modal fed-batch culture
using a set point of high limit. Journal of Fermentation and Bioengineering 69:292-297.
• Taylor, A., D. P. Brown, S. Kadam, M. Maus, W. E. Kohlbrenner, D. Weigl, M. C.
Turon, and L. Katz. 1992. High-level expression and purification of mature HIV-1
protease in Escherichia coli under control of the araBAD promoter. Appl Microbial
Biotechnol 37:205-10.
• Timasheff, S. N. 1998. In disperse solution, "osmotic stress" is a restricted case of
preferential interactions. Proc Natl Acad Sci US A 95:7363-7.
• Tomich, C. S., E. R. Olson, M. K. Olsen, P. S. Kaytes, S. K. Rockenbach, and N. T.
Hatzenbuhler .. 1989. Effect of nucleotide sequences directly downstream from the AUG
on the expression of bovine somatotropin in E. coli. Nucleic Acids Res 17:3179-97.
• Toyofuku, K., T. Umemura, and J. Yamaguchi. 1998. Promoter elements required for
sugar-repression of the RAmy3D gene for alpha-amylase in rice. FEBS Lett 428:275-80.
144
Bibliography
• Turner, C., Gregory, M.E., Turner, M.K, 1994 A Study of the Effect of Specific Growth
rate and Acetate on Recombinant Protein-production of Escherichia coli JM 1 07,
Biotechnol Letters, 16, No.9, 891-896.
• V Shin CS, Hong MS, Bae CS, Lee J. 1997. Enhanced production of human mini
proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21 (DE3)[pET-
3aT2M2]. Biotechnol Prog 13:249-57.
• Vaidyanathan, S., S. A. Arnold, L. Matheson, P. Mohan, B. McNeil, and L. M.
Harvey. 2001. Assessment of near-infrared spectral information for rapid monitoring of
bioprocess quality. Biotechnol Bioeng 74:376-88.
• van de Walle, M., and J. Shiloach. 1998. Proposed mechanism of acetate
accumulation in two recombinant Escherichia coli strains during high density
fermentation. Biotechnol Bioeng 57:71-8.
• Vasquez, J. R., L. B. Evnin, J. N. Higaki, and C. S. Craik. 1989. An expression system
for trypsin. J Cell Biochem 39:265-76.
• Vemuri, G. N., E. Altman, D. P. Sangurdekar, A. B. Khodursky, and M. A. Eiteman.
2006. Overflow metabolism in Escherichia coli during steady-state growth: transcriptional
regulation and effect of the redox ratio. Appl Environ Microbial 72:3653-61.
• Wan, E. W., and F. Baneyx. 1998. ToiAIII co-overexpression facilitates the recovery of
periplasmic recombinant proteins into the growth medium of Escherichia coli. Protein
Expr Purif 14:13-22.
• Wang, F., and S. Y. Lee. 1998. High cell density culture of metabolically engineered
Escherichia coli for the production of poly(3-hydroxybutyrate) in a defined medium.
Biotechnol Bioeng 58:325-8.
• Warburton, N., P. G. Boseley, and A. G. Porter. 1983. Increased expression of a
cloned gene by local mutagenesis of its promoter and ribosome binding site. Nucleic
Acids Res 11:5837-54.
• Watts, M. J., I. Addison, S. G. Long, S. Hartley, S. Warrington, M. Boyce, and D. C.
Linch. 1997. Crossover study of the haematological effects and pharmacokinetics of
glycosylated and non-glycosylated G-CSF in healthy volunteers. Br J Haematol 98:474-
9.
• Weikert, C., U. Sauer, and J. E. Bailey. 1998. An Escherichia coli host strain useful for
145
Bibliography
efficient overproduction of secreted recombinant protein. Biotechnol Bioeng 59:386-91.
• Welte, K., J. Gabrilove, M. H. Bronchud, E. Platzer, and G. Morstyn. 1996. Filgrastim
(r-metHuG-CSF): the first 10 years. Blood 88:1907-29.
• Wingfield, P., R. Benedict, G. Turcatti, B. Allet, J. J. Mermod, J. Delamarter, M.G.
Simona, and K. Rose. 1988. Characterization of recombinant-derived granulocyte
colony stimulating factor (G-CSF). Biochem J 256:213-8.
• Woestenenk, E. A., M. Hammarstrom, S. van den Berg, T. Hard, and H. Berglund.
2004. His tag effect on solubility of human proteins produced in Escherichia coli: a
comparison between four expression vectors. J Struct Funct Genomics 5:217-29.
• Wolf, G., J. S. Almeida, C. Pinheiro, V. Correia, C. Rodrigues, M. A. Reis, and J. G.
Crespo. 2001. Two-dimensional fluorometry coupled with artificial neural networks: a
novel method for on-line monitoring of complex biological processes. Biotechnol Bioeng
72:297-306.
• Wong, H. H., Y. C. Kim, S. Y. Lee, and H. N. Chang. 1998. Effect of post-induction
nutrient feeding strategies on the production of bioadhesive protein in Escherichia coli.
Biotechnol Bioeng 60:271-6.
• Yamaguchi, T., M. Kogi, Y. Yamamoto, and T. Hayakawa. 1997. Bioassay of human
granulocyte colony-stimulating factor using human promyelocytic HL-60 cells. Bioi
Pharm Bull 20:943-7.
• Yardley, J. E., D. B. Kell, J. Barrett, and C. L. Davey. 2000. On-line. real-time
measurements of cellular biomass using dielectric spectroscopy. Biotechnol Genet Eng
Rev 17:3-35.
• Yee, L., and H. W. Blanch. 1992. Recombinant protein expression in high cell density
fed-batch cultures of Escherichia coli. Biotechnology (N Y) 10:1550-6.
• Yuo, A., S. Kitagawa, A. Ohsaka, M. Ohta, K. Miyazono, T. Okabe, A. Urabe, M.
Saito, and F. Takaku. 1989. Recombinant human granulocyte colony-stimulating factor
as an activator of human granulocytes: potentiation of responses triggered by receptor
mediated agonists and stimulation of C3bi receptor expression and adherence. Blood
74:2144-9.
• Zahn, K. 1996. Overexpression of an mRNA dependent on rare codons inhibits protein
synthesis and cell growth. J Bacterio1178:2926-33.
146
Bibliography
• Zhang, Z., J. Gildersleeve, Y. Y. Yang, R. Xu, J. A. Loo, S. Uryu, C. H. Wong, and P.
G. Schultz. 2004. A new strategy for the synthesis of glycoproteins. Science 303:371-3.
• Zsebo, K. M., A. M. Cohen, D. C. Murdock, T. C. Boone, H. Inoue, V. R. Chazin, D.
Hines, and L. M. Souza. 1986. Recombinant human granulocyte colony stimulating
factor: molecular and biological characterization. lmmunobiology 172:175-84.
• Zsebo, K. M., V. N. Yuschenkoff, S. Schiffer, D. Chang, E. McCall, C. A. Dinarello,
M. A. Brown, B. Altrock, and G. C. Bagby, Jr. 1988. Vascular endothelial cells and
granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 71:99-
103.
147
